Aarhus University logo
Where are they now? Meet NCMM alumnus Jaime Castro-Mondragón and learn how he used his network to build relationships and his career.
For five years, a European research project will investigate the long-term neurological and psychiatric symptoms following infection with SARS-CoV-2 that causes COVID-19, something that is becoming a societal problem. Umeå University is one of ten universities in seven countries that are part of the project.
Overall, the Neurocov project is about understanding the interaction between the central and peripheral nervous system and the inflammatory response that the immune system triggers during COVID-19 infection.
Dr Tatiana Belova (NCMM), Dr Salim Ghannoum (Oslo University Hospital) and Saikat Das Sajib (University of Tromsø) have been awarded the funding by the national network for breast cancer research
Meet FIMM Group Leader, Helena Kilpinen, and learn how she harnesses the power of induced pluripotent stem cell technology to study rare neurodevelopmental disorders.
We are very happy to announce that we have recruited a new Group Leader to DANDRITE’s portfolio of top researchers. Chao Sun is currently an EMBO & HFSP postdoctoral fellow at the Max Planck Institute for Brain Research in Frankfurt, Germany. Chao will join DANDRITE in the Spring of 2023 and will be located at the Department of Molecular Biology and Genetics.
Researchers have, for the first time, systematically estimated the impact of a range of different disease-associated genetic risk factors on the loss of healthy life years. Knowing the contribution of different genetic risk factors on disease burden can help prioritise and design interventions using genetic data.
FIMM researchers contribute to the REMEDi4ALL project that kicks off with the ambition of establishing a European research and innovation eco-system that facilitates fast and cost-effective patient-centric development and access to repurposed medicines. The project involves 24 European organisations.
The Functional Precision Medicine for Blood Cancer Workshop & Symposium is an annual event that brings together biomedical and clinical researchers…
Members of EMBL Partnerships will convene in Heidelberg, Germany.
Researchers have, for the first time, systematically estimated the impact of a range of different disease-associated genetic risk factors on the loss of healthy life years. The new study, published in Nature Medicine, shows the impact of different genetic risk factors on disease burden can help prioritise and design interventions using genetic data.